# Efficacy of 0.2 % Digluconate Chlorhexidine Mouthwash for Preventing Alveolar Osteitis After Third Molar Extraction

> **NCT02382809** · PHASE4 · COMPLETED · sponsor: **Pierre Fabre Medicament** · enrollment: 414 (actual)

## Conditions studied

- Alveolar Osteitis

## Interventions

- **DRUG:** DC071
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02382809
- **Lead sponsor:** Pierre Fabre Medicament
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03
- **Primary completion:** 2016-02
- **Final completion:** 2016-02
- **Target enrollment:** 414 (ACTUAL)
- **Last updated:** 2016-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02382809

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02382809, "Efficacy of 0.2 % Digluconate Chlorhexidine Mouthwash for Preventing Alveolar Osteitis After Third Molar Extraction". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02382809. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*